Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, B-Cell × zanubrutinib × Clear all

Phase

Phase 3 2 Phase 2 2 Phase NA 1 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 2 Multiple Myeloma 1 Lymphoma, B-Cell 1 Lymphohistiocytosis, Hemophagocytic 1

Interventions

relmacabtagene autoleucel 2 zanubrutinib 1 ibrutinib 1 axicabtagene ciloleucel 1 Rituximab 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07270835 2025-12-08

Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma

The First Affiliated Hospital of Soochow University

Phase 4 Recruiting

LymphoidMyeloid

Lymphoma, B-Cell, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡